Drugs that contain Hydrocodone Bitartrate

1. Drug name - HYSINGLA ER

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10369109 PURDUE PHARMA LP Abuse-proofed dosage form Jun, 2023

(8 months from now)

US9675610 PURDUE PHARMA LP Abuse-proofed dosage form Jun, 2023

(8 months from now)

US10130591 PURDUE PHARMA LP Abuse-proofed dosage form Nov, 2023

(1 year, 1 month from now)

US8309060 PURDUE PHARMA LP Abuse-proofed dosage form Nov, 2023

(1 year, 1 month from now)

US9775809 PURDUE PHARMA LP Tamper resistant dosage forms Aug, 2027

(4 years from now)

US9492389 PURDUE PHARMA LP Tamper resistant dosage forms Aug, 2027

(4 years from now)

US9492390 PURDUE PHARMA LP Tamper resistant dosage forms Aug, 2027

(4 years from now)

US9545380 PURDUE PHARMA LP Tamper resistant dosage forms Aug, 2027

(4 years from now)

US9486412 PURDUE PHARMA LP Tamper resistant dosage forms Aug, 2027

(4 years from now)

US9492391 PURDUE PHARMA LP Tamper resistant dosage forms Aug, 2027

(4 years from now)

US9095614 PURDUE PHARMA LP Tamper resistant dosage forms Aug, 2027

(4 years from now)

US9763933 PURDUE PHARMA LP Tamper resistant dosage forms Aug, 2027

(4 years from now)

US9095615 PURDUE PHARMA LP Tamper resistant dosage forms Aug, 2027

(4 years from now)

US9770416 PURDUE PHARMA LP Tamper resistant dosage forms Aug, 2027

(4 years from now)

US9486413 PURDUE PHARMA LP Tamper resistant dosage forms Aug, 2027

(4 years from now)

US9084816 PURDUE PHARMA LP Tamper resistant dosage forms Aug, 2027

(4 years from now)

US9750703 PURDUE PHARMA LP Encased tamper resistant controlled release dosage forms Dec, 2031

(9 years from now)

US9572779 PURDUE PHARMA LP Encased tamper resistant controlled release dosage forms Dec, 2031

(9 years from now)

US9861584 PURDUE PHARMA LP Tamper resistant controlled release dosage forms Dec, 2031

(9 years from now)

US9872837 PURDUE PHARMA LP Tamper resistant controlled release dosage forms Dec, 2031

(9 years from now)

US8808740 PURDUE PHARMA LP Encased tamper resistant controlled release dosage forms Dec, 2031

(9 years from now)

Treatment: Management of pain severe enough to require daily, around-the-clock, long term opioid treatment and for which alternative treatment options are inadequate; Management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate

Dosage: TABLET, EXTENDED RELEASE;ORAL

More Information on Dosage
Strength Dosage Availability
20MG TABLET, EXTENDED RELEASE;ORAL Prescription
30MG TABLET, EXTENDED RELEASE;ORAL Prescription
40MG TABLET, EXTENDED RELEASE;ORAL Prescription
60MG TABLET, EXTENDED RELEASE;ORAL Prescription
80MG TABLET, EXTENDED RELEASE;ORAL Prescription
100MG TABLET, EXTENDED RELEASE;ORAL Prescription
120MG TABLET, EXTENDED RELEASE;ORAL Prescription

2. Drug name - VANTRELA ER

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9216176 TEVA BRANDED PHARM Abuse resistant drug formulation Sep, 2027

(4 years from now)

US9572803 TEVA BRANDED PHARM Abuse resistant drug formulation Sep, 2027

(4 years from now)

US8445018 TEVA BRANDED PHARM Abuse resistant drug formulation Jul, 2029

(6 years from now)

Treatment: NA

Dosage: TABLET, EXTENDED RELEASE;ORAL

More Information on Dosage
Strength Dosage Availability
15MG TABLET, EXTENDED RELEASE;ORAL Discontinued
30MG TABLET, EXTENDED RELEASE;ORAL Discontinued
45MG TABLET, EXTENDED RELEASE;ORAL Discontinued
60MG TABLET, EXTENDED RELEASE;ORAL Discontinued
90MG TABLET, EXTENDED RELEASE;ORAL Discontinued

3. Drug name - ZOHYDRO ER

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9339499 RECRO GAINESVILLE Treating pain in patients with hepatic impairment Jul, 2033

(10 years from now)

US10456393 RECRO GAINESVILLE Treating pain in patients with hepatic impairment Jul, 2033

(10 years from now)

US10722511 RECRO GAINESVILLE Treating pain in patients with hepatic impairment Jul, 2033

(10 years from now)

US10322120 RECRO GAINESVILLE Treating pain in patients with hepatic impairment Jul, 2033

(10 years from now)

US9326982 RECRO GAINESVILLE Treating pain in patients with hepatic impairment Jul, 2033

(10 years from now)

US9265760 RECRO GAINESVILLE Treating pain in patients with hepatic impairment Jul, 2033

(10 years from now)

US9610286 RECRO GAINESVILLE Treating pain in patients with hepatic impairment Jul, 2033

(10 years from now)

US9333201 RECRO GAINESVILLE Treating pain in patients with hepatic impairment Jul, 2033

(10 years from now)

US9421200 RECRO GAINESVILLE Treating pain in patients with hepatic impairment Jul, 2033

(10 years from now)

US10028946 RECRO GAINESVILLE Treating pain in patients with hepatic impairment Jul, 2033

(10 years from now)

US9433619 RECRO GAINESVILLE Treating pain in patients with hepatic impairment Jul, 2033

(10 years from now)

US9132096 RECRO GAINESVILLE Abuse resistant pharmaceutical compositions Sep, 2034

(11 years from now)

US9486451 RECRO GAINESVILLE Abuse resistant pharmaceutical compositions Sep, 2034

(11 years from now)

US9713611 RECRO GAINESVILLE Abuse resistant pharmaceutical compositions Sep, 2034

(11 years from now)

US10092559 RECRO GAINESVILLE Abuse resistant pharmaceutical compositions Sep, 2034

(11 years from now)

US9452163 RECRO GAINESVILLE Abuse resistant pharmaceutical compositions Sep, 2034

(11 years from now)

Treatment: Treatment of pain in patients with hepatic impairment; Treatment of pain

Dosage: CAPSULE, EXTENDED RELEASE;ORAL

More Information on Dosage
Strength Dosage Availability
10MG CAPSULE, EXTENDED RELEASE;ORAL Discontinued
15MG CAPSULE, EXTENDED RELEASE;ORAL Discontinued
20MG CAPSULE, EXTENDED RELEASE;ORAL Discontinued
30MG CAPSULE, EXTENDED RELEASE;ORAL Discontinued
40MG CAPSULE, EXTENDED RELEASE;ORAL Discontinued
50MG CAPSULE, EXTENDED RELEASE;ORAL Discontinued

availability in other generic markets.

Click on the highlighted region to filter.